Position in DXCM
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$363,083
+$39,538 QoQ
Shares Held
5,391
+4.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#632
of 971 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Brookstone Capital Management holds $9,849,964 across 9 Medical Devices names. DXCM ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
36,431 | $3,305,748 | |
| 2 | MDT |
Medtronic plc
|
27,821 | $2,176,436 | |
| 3 | SYK |
Stryker Corp
|
3,993 | $1,257,156 | |
| 4 | PODD |
Insulet Corp
|
5,656 | $861,126 | |
| 5 | BSX |
Boston Scientific Corp
|
16,783 | $716,298 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
8,215 | $707,229 | |
| 7 | DXCM |
Dexcom Inc
This page
|
5,391 | $363,083 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
3,690 | $236,196 |
All Filings in DXCM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $363,083 | 5,391 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $323,545 | 5,152 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $276,231 | 4,162 | Shares | Sole | 2026-01-15 | |
| No filing history on record for this holder in this stock. | ||||||